[1]
G. Limbong, “ANALYSIS OF THE COMPANY’S FINANCIAL PERFORMANCE BEFORE AND DURING THE COVID-19 PANDEMIC (2019-2020) IN PHARMACEUTICAL SECTOR COMPANIES LISTED ON THE IDX”, JM, vol. 10, no. 2, pp. 156-165, Apr. 2022.